{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:27:18Z","timestamp":1793039238743,"version":"4.5.0"},"reference-count":117,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,12,22]]},"DOI":"10.1001\/jama.2020.21360","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T16:43:42Z","timestamp":1608655422000},"page":"2536","source":"Crossref","is-referenced-by-count":382,"title":["Gastroesophageal Reflux Disease"],"prefix":"10.1001","volume":"324","author":[{"given":"John","family":"Maret-Ouda","sequence":"first","affiliation":[{"name":"Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden"},{"name":"Centre for Clinical Research Sormland, Uppsala University, Eskilstuna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheraz R.","family":"Markar","sequence":"additional","affiliation":[{"name":"Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Surgery and Cancer, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[{"name":"Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden"},{"name":"School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"jrv200015r1","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/ajg.2006.101.issue-8","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"jrv200015r2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2017.07.045","article-title":"Presentation and epidemiology of gastroesophageal reflux disease.","volume":"154","author":"Richter","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"jrv200015r3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","article-title":"Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.","volume":"67","author":"Eusebi","year":"2018","journal-title":"Gut"},{"issue":"8-S","key":"jrv200015r4","first-page":"40","article-title":"Relationship between Helicobacter pylori infection and GERD.","volume":"89","author":"Scida","year":"2018","journal-title":"Acta Biomed"},{"issue":"6","key":"jrv200015r5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"issue":"8","key":"jrv200015r6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1365-2036.2003.01770.x","article-title":"Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: an analysis based on the ProGERD initiative.","volume":"18","author":"Kulig","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"jrv200015r7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/apt.2011.34.issue-6","article-title":"Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.","volume":"34","author":"Becher","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"jrv200015r8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrgastro.2017.130","article-title":"Expert consensus document: advances in the physiological assessment and diagnosis of GERD.","volume":"14","author":"Savarino","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"jrv200015r9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.suc.2015.02.006","article-title":"Physiology and pathogenesis of gastroesophageal reflux disease.","volume":"95","author":"Mikami","year":"2015","journal-title":"Surg Clin North Am"},{"issue":"1","key":"jrv200015r10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/20469047.2018.1489649","article-title":"Gastroesophageal reflux disease (GERD) in children.","volume":"39","author":"Poddar","year":"2019","journal-title":"Paediatr Int Child Health"},{"issue":"22","key":"jrv200015r11","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1056\/NEJMoa054391","article-title":"Body-mass index and symptoms of gastroesophageal reflux in women.","volume":"354","author":"Jacobson","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"jrv200015r12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? an evidence-based approach.","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med"},{"issue":"8","key":"jrv200015r13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/gut.52.8.1085","article-title":"Genetic influences in gastro-oesophageal reflux disease: a twin study.","volume":"52","author":"Mohammed","year":"2003","journal-title":"Gut"},{"issue":"1","key":"jrv200015r14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/gast.2002.30301","article-title":"Gastroesophageal reflux disease in monozygotic and dizygotic twins.","volume":"122","author":"Cameron","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"jrv200015r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nmo.2017.29.issue-2","article-title":"Insights into the genetics of gastroesophageal reflux disease (GERD) and GERD-related disorders.","volume":"29","author":"B\u00f6hmer","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"jrv200015r16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/apt.14414","article-title":"Genetic risk factors for perception of symptoms in GERD: an observational cohort study.","volume":"47","author":"Patel","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"jrv200015r17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9093007","article-title":"Endoscopic reflux esophagitis and reflux-related symptoms after Helicobacter pylori eradication therapy: meta-analysis.","volume":"9","author":"Sugimoto","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"jrv200015r18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease.","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"jrv200015r19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0000000000001907","article-title":"Diagnosis and treatment of the extraesophageal manifestations of gastroesophageal reflux disease.","volume":"265","author":"Sidhwa","year":"2017","journal-title":"Ann Surg"},{"issue":"4","key":"jrv200015r20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.pop.2017.07.001","article-title":"Gastroesophageal reflux disease.","volume":"44","author":"Kellerman","year":"2017","journal-title":"Prim Care"},{"issue":"8","key":"jrv200015r21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S2468-1253(17)30001-8","article-title":"Oesophageal dysphagia: a stepwise approach to diagnosis and management.","volume":"2","author":"Johnston","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"jrv200015r22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease.","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"jrv200015r23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0002-9343(97)00354-9","article-title":"The impact of gastroesophageal reflux disease on health-related quality of life.","volume":"104","author":"Revicki","year":"1998","journal-title":"Am J Med"},{"issue":"1","key":"jrv200015r24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1368-5031.2006.00768.x","article-title":"Long-term management of patients with symptoms of gastro-oesophageal reflux disease: a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting.","volume":"60","author":"Hansen","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"2","key":"jrv200015r25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/gutjnl-2016-312514","article-title":"All-cause and cancer-specific mortality in GORD in a population-based cohort study (the HUNT study).","volume":"67","author":"Ness-Jensen","year":"2018","journal-title":"Gut"},{"issue":"3","key":"jrv200015r26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/00365520510011579","article-title":"High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report.","volume":"40","author":"Ronkainen","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"jrv200015r27","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1136\/gut.2007.145177","article-title":"Gastro-oesophageal reflux symptoms, oesophagitis and Barrett\u2019s oesophagus in the general population: the Loiano-Monghidoro study.","volume":"57","author":"Zagari","year":"2008","journal-title":"Gut"},{"issue":"1","key":"jrv200015r28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/gast.1996.v111.pm8698230","article-title":"The endoscopic assessment of esophagitis: a progress report on observer agreement.","volume":"111","author":"Armstrong","year":"1996","journal-title":"Gastroenterology"},{"issue":"2","key":"jrv200015r29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification.","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"issue":"1","key":"jrv200015r30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000210101","article-title":"Peptic esophageal stricture: medical treatment.","volume":"27","author":"Pregun","year":"2009","journal-title":"Dig Dis"},{"issue":"1","key":"jrv200015r31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/17474124.2017.1260002","article-title":"Endoscopic treatment of benign esophageal strictures: a literature review.","volume":"11","author":"Poincloux","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9","key":"jrv200015r32","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMra1314704","article-title":"Barrett\u2019s esophagus.","volume":"371","author":"Spechler","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"jrv200015r33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/des.2010.23.issue-6","article-title":"The prevalence of Barrett\u2019s esophagus in the US: estimates from a simulation model confirmed by SEER data.","volume":"23","author":"Hayeck","year":"2010","journal-title":"Dis Esophagus"},{"key":"jrv200015r34","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-321365","article-title":"Global prevalence of Barrett\u2019s oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.","author":"Eusebi","year":"2020","journal-title":"Gut"},{"issue":"6","key":"jrv200015r35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.gie.2014.01.009","article-title":"Incidence of esophageal adenocarcinoma in Barrett\u2019s esophagus with low-grade dysplasia: a systematic review and meta-analysis.","volume":"79","author":"Singh","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"jrv200015r36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cgh.2017.11.044","article-title":"Factors associated with progression of Barrett\u2019s esophagus: a systematic review and meta-analysis.","volume":"16","author":"Krishnamoorthi","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"jrv200015r37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/ajg.2015.55","article-title":"BOB CAT: a large-scale review and Delphi consensus for management of Barrett\u2019s esophagus with no dysplasia, indefinite for, or low-grade dysplasia.","volume":"110","author":"Bennett","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"jrv200015r38","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","article-title":"American Gastroenterological Association medical position statement on the management of Barrett\u2019s esophagus.","volume":"140","author":"Spechler","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"jrv200015r39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus.","volume":"63","author":"Fitzgerald","year":"2014","journal-title":"Gut"},{"issue":"6","key":"jrv200015r40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1001\/jama.2013.226450","article-title":"Barrett esophagus and risk of esophageal cancer: a clinical review.","volume":"310","author":"Spechler","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"jrv200015r41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.","volume":"340","author":"Lagergren","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv200015r42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2017.07.046","article-title":"The epidemiology of esophageal adenocarcinoma.","volume":"154","author":"Coleman","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"jrv200015r43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.canep.2012.07.009","article-title":"Oesophageal cancer survival in Europe: a EUROCARE-4 study.","volume":"36","author":"Gavin","year":"2012","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"jrv200015r44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/jgh.2016.31.issue-6","article-title":"Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis.","volume":"31","author":"Njei","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"jrv200015r45","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1097\/CEJ.0000000000000308","article-title":"Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study.","volume":"26","author":"Launoy","year":"2017","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"jrv200015r46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3322\/caac.21185","article-title":"Recent developments in esophageal adenocarcinoma.","volume":"63","author":"Lagergren","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"jrv200015r47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169691","article-title":"Proton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis.","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS One"},{"issue":"10145","key":"jrv200015r48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(18)31388-6","article-title":"Esomeprazole and aspirin in Barrett\u2019s oesophagus (AspECT): a randomised factorial trial.","volume":"392","author":"Jankowski","year":"2018","journal-title":"Lancet"},{"key":"jrv200015r49","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003709","article-title":"Esophageal adenocarcinoma after antireflux surgery in a cohort study from the 5 Nordic countries.","author":"Maret-Ouda","year":"2019","journal-title":"Ann Surg"},{"issue":"2","key":"jrv200015r50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/SLA.0000000000001438","article-title":"Antireflux surgery and risk of esophageal adenocarcinoma: a systematic review and meta-analysis.","volume":"263","author":"Maret-Ouda","year":"2016","journal-title":"Ann Surg"},{"issue":"5","key":"jrv200015r51","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/SLA.0000000000002890","article-title":"The influence of antireflux surgery on esophageal cancer risk in England: national population-based cohort study.","volume":"268","author":"Markar","year":"2018","journal-title":"Ann Surg"},{"issue":"11","key":"jrv200015r52","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s00464-010-1267-8","article-title":"Guidelines for surgical treatment of gastroesophageal reflux disease.","volume":"24","author":"Stefanidis","year":"2010","journal-title":"Surg Endosc"},{"issue":"4","key":"jrv200015r54","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jama.289.4.466","article-title":"A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus.","volume":"289","author":"Spechler","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"jrv200015r55","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2018.8694","article-title":"Esophageal high-resolution manometry in gastroesophageal reflux disease.","volume":"320","author":"Patel","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"jrv200015r56","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon Consensus.","volume":"67","author":"Gyawali","year":"2018","journal-title":"Gut"},{"issue":"5","key":"jrv200015r57","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bpg.2017.09.004","article-title":"Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease.","volume":"31","author":"Ness-Jensen","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"jrv200015r58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cgh.2015.04.176","article-title":"Lifestyle intervention in gastroesophageal reflux disease.","volume":"14","author":"Ness-Jensen","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"jrv200015r59","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1001\/jamaoto.2017.1454","article-title":"A comparison of alkaline water and Mediterranean diet vs proton pump inhibition for treatment of laryngopharyngeal reflux.","volume":"143","author":"Zalvan","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"2","key":"jrv200015r60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056060","article-title":"Proton pump inhibitor use in the US ambulatory setting, 2002-2009.","volume":"8","author":"Rotman","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"jrv200015r61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208461","article-title":"A cross-sectional study of national outpatient gastric acid suppressant prescribing in the United States between 2009 and 2015.","volume":"13","author":"Bustillos","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"jrv200015r62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/intqhc\/mzw138","article-title":"Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change.","volume":"29","author":"Pratt","year":"2017","journal-title":"Int J Qual Health Care"},{"issue":"6","key":"jrv200015r63","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/imj.2015.45.issue-6","article-title":"Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013.","volume":"45","author":"Nishtala","year":"2015","journal-title":"Intern Med J"},{"issue":"1","key":"jrv200015r64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.12927\/hcq","article-title":"Drug use among seniors on public drug programs in Canada, 2012.","volume":"18","author":"Proulx","year":"2015","journal-title":"Healthc Q"},{"issue":"6","key":"jrv200015r65","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cgh.2017.09.033","article-title":"Interchangeable use of proton pump inhibitors based on relative potency.","volume":"16","author":"Graham","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"jrv200015r66","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/1756283X16650156","article-title":"Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study.","volume":"9","author":"Potteg\u00e5rd","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"jrv200015r67","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818777943","article-title":"Proton-pump inhibitors among adults: a nationwide drug-utilization study.","volume":"11","author":"H\u00e1lfd\u00e1narson","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"issue":"4","key":"jrv200015r68","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association.","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"22","key":"jrv200015r69","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1056\/NEJMoa1002689","article-title":"Use of proton-pump inhibitors in early pregnancy and the risk of birth defects.","volume":"363","author":"Pasternak","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv200015r70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2165\/11597290-000000000-00000","article-title":"Are proton pump inhibitors safe during pregnancy and lactation? evidence to date.","volume":"72","author":"Majithia","year":"2012","journal-title":"Drugs"},{"issue":"12","key":"jrv200015r71","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jama.2018.1144","article-title":"Gastroesophageal reflux monitoring.","volume":"319","author":"Patel","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"jrv200015r72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin.","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"jrv200015r73","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/ndt\/gfw470","article-title":"The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.","volume":"33","author":"Nochaiwong","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"jrv200015r74","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/phar.2019.39.issue-4","article-title":"Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study.","volume":"39","author":"Hart","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"1","key":"jrv200015r75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jhin.2017.08.017","article-title":"Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection.","volume":"98","author":"Cao","year":"2018","journal-title":"J Hosp Infect"},{"issue":"5","key":"jrv200015r76","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/intqhc\/mzaa041","article-title":"Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.","volume":"32","author":"Nguyen","year":"2020","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"jrv200015r77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-020-00688-1","article-title":"Medications as a risk factor for fragility hip fractures: a systematic review and meta-analysis.","volume":"107","author":"Mortensen","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"jrv200015r78","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101585","article-title":"Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer.","volume":"62","author":"Brusselaers","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"jrv200015r79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"},{"issue":"2","key":"jrv200015r80","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41416-020-0860-4","article-title":"Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.","volume":"123","author":"Liu","year":"2020","journal-title":"Br J Cancer"},{"issue":"5","key":"jrv200015r81","doi-asserted-by":"publisher","first-page":"706","DOI":"10.14309\/ajg.0000000000000591","article-title":"Proton pump inhibitor use and risk of gastric, colorectal, liver, and pancreatic cancers in a community-based population.","volume":"115","author":"Lee","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"21","key":"jrv200015r85","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.3390\/ijms20215469","article-title":"Problems associated with deprescribing of proton pump inhibitors.","volume":"20","author":"Helgadottir","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"jrv200015r86","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/ajg.2018.29","article-title":"Discontinuing long-term PPI therapy: why, with whom, and how?","volume":"113","author":"Targownik","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"jrv200015r87","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.gastro.2017.07.049","article-title":"Management of gastroesophageal reflux disease.","volume":"154","author":"Gyawali","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"jrv200015r90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dow020","article-title":"Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.","volume":"30","author":"Leiman","year":"2017","journal-title":"Dis Esophagus"},{"issue":"8","key":"jrv200015r91","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1053\/j.gastro.2020.02.031","article-title":"IW-3718 reduces heartburn severity in patients with refractory gastroesophageal reflux disease in a randomized trial.","volume":"158","author":"Vaezi","year":"2020","journal-title":"Gastroenterology"},{"key":"jrv200015r92","first-page":"590","article-title":"[A simple operation for control of reflux esophagitis].","volume":"86","author":"Nissen","year":"1956","journal-title":"Schweiz Med Wochenschr"},{"issue":"11","key":"jrv200015r93","article-title":"Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults.","author":"Garg","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"jrv200015r94","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamasurg.2019.0047","article-title":"Comparison of laparoscopic 270\u00b0 posterior partial fundoplication vs total fundoplication for the treatment of gastroesophageal reflux disease: a randomized clinical trial.","volume":"154","author":"H\u00e5kanson","year":"2019","journal-title":"JAMA Surg"},{"key":"jrv200015r95","doi-asserted-by":"publisher","first-page":"h3169","DOI":"10.1136\/bmj.h3169","article-title":"What is the most effective treatment for severe gastro-oesophageal reflux disease?","volume":"350","author":"Maret-Ouda","year":"2015","journal-title":"BMJ"},{"issue":"19","key":"jrv200015r96","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2011.626","article-title":"Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.","volume":"305","author":"Galmiche","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"jrv200015r97","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41395-018-0115-7","article-title":"Complications of antireflux surgery.","volume":"113","author":"Yadlapati","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"jrv200015r98","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jama.2017.10981","article-title":"Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux.","volume":"318","author":"Maret-Ouda","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"jrv200015r99","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00464-007-9705-y","article-title":"Complications and frequency of redo antireflux surgery in Denmark: a nationwide study, 1997-2005.","volume":"22","author":"Funch-Jensen","year":"2008","journal-title":"Surg Endosc"},{"issue":"3","key":"jrv200015r100","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00464-014-3660-1","article-title":"Reoperation rates after laparoscopic fundoplication.","volume":"29","author":"Zhou","year":"2015","journal-title":"Surg Endosc"},{"issue":"6","key":"jrv200015r101","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamasurg.2014.3859","article-title":"Analysis of the causes of failed antireflux surgery and the principles of treatment: a review.","volume":"150","author":"Patti","year":"2015","journal-title":"JAMA Surg"},{"issue":"5","key":"jrv200015r102","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/109264201317054546","article-title":"Initial experience with the Stretta procedure for the treatment of gastroesophageal reflux disease.","volume":"11","author":"Richards","year":"2001","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"24","key":"jrv200015r103","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.3748\/wjg.v20.i24.7730","article-title":"Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease.","volume":"20","author":"Triadafilopoulos","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"jrv200015r104","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1007\/s00464-017-5431-2","article-title":"Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease.","volume":"31","author":"Fass","year":"2017","journal-title":"Surg Endosc"},{"issue":"2","key":"jrv200015r105","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00464-007-9618-9","article-title":"Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study.","volume":"22","author":"Cadi\u00e8re","year":"2008","journal-title":"Surg Endosc"},{"issue":"1","key":"jrv200015r106","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/SLA.0b013e31817c9630","article-title":"Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device.","volume":"248","author":"Jobe","year":"2008","journal-title":"Ann Surg"},{"issue":"5","key":"jrv200015r107","doi-asserted-by":"publisher","first-page":"E647","DOI":"10.1055\/a-0820-2297","article-title":"Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years.","volume":"7","author":"Testoni","year":"2019","journal-title":"Endosc Int Open"},{"issue":"1","key":"jrv200015r108","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1553350614526788","article-title":"Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial.","volume":"22","author":"Trad","year":"2015","journal-title":"Surg Innov"},{"issue":"2","key":"jrv200015r109","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1553350618755214","article-title":"The TEMPO trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective.","volume":"25","author":"Trad","year":"2018","journal-title":"Surg Innov"},{"issue":"4","key":"jrv200015r110","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ajg.2015.28","article-title":"Randomized controlled trial of transoral incisionless fundoplication vs proton pump inhibitors for treatment of gastroesophageal reflux disease.","volume":"110","author":"Witteman","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"jrv200015r111","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJMoa1205544","article-title":"Esophageal sphincter device for gastroesophageal reflux disease.","volume":"368","author":"Ganz","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"jrv200015r112","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1007\/s11605-008-0698-1","article-title":"Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial.","volume":"12","author":"Bonavina","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"jrv200015r113","first-page":"291","article-title":"Spotlight on the Lin Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research.","volume":"11","author":"Zadeh","year":"2018","journal-title":"Med Devices (Auckl)"},{"issue":"9","key":"jrv200015r114","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamasurg.2017.1606","article-title":"Standard vs expanded indications for esophageal magnetic sphincter augmentation for reflux disease.","volume":"152","author":"Kuckelman","year":"2017","journal-title":"JAMA Surg"},{"issue":"4","key":"jrv200015r115","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/dote.12199","article-title":"Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease.","volume":"28","author":"Lipham","year":"2015","journal-title":"Dis Esophagus"},{"issue":"1","key":"jrv200015r116","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gie.2018.07.007","article-title":"Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.","volume":"89","author":"Bell","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"jrv200015r117","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doz031","article-title":"Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis.","volume":"32","author":"Guidozzi","year":"2019","journal-title":"Dis Esophagus"},{"key":"jrv200015r53","author":"National Institute for Clinical Excellence","year":"2019"},{"key":"jrv200015r82","unstructured":"Oxford Centre for Evidence-based Medicine. Levels of evidence. Accessed June 17, 2020. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/"},{"key":"jrv200015r83","unstructured":"Food and Drug Administration. FDA drug safety communication: Clostridium difficile associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). Accessed June 15, 2020. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-clostridium-difficile-associated-diarrhea-can-be-associated-stomach"},{"key":"jrv200015r84","unstructured":"Food and Drug Administration. FDA drug safety communication: possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. Accessed June 18, 2020. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fda-drug-safety-communication-possible-increased-risk-fractures-hip-wrist-and-spine-use-proton-pump"},{"key":"jrv200015r88","unstructured":"Food and Drug Administration. FDA requests removal of all ranitidine products (Zantac) from the market. Accessed May 31, 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-requests-removal-all-ranitidine-products-zantac-market"},{"key":"jrv200015r89","unstructured":"European Medicines Agency. Suspension of ranitidine medicines in the EU. Accessed May 31, 2020. https:\/\/www.ema.europa.eu\/en\/news\/suspension-ranitidine-medicines-eu"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2774414\/jama_maretouda_2020_rv_200015_1607962926.41251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T16:43:54Z","timestamp":1608655434000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2774414"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":117,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,12,22]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.21360","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,22]]}}}